CN104000777B - A kind of levofloxacin preparation - Google Patents

A kind of levofloxacin preparation Download PDF

Info

Publication number
CN104000777B
CN104000777B CN201410222398.3A CN201410222398A CN104000777B CN 104000777 B CN104000777 B CN 104000777B CN 201410222398 A CN201410222398 A CN 201410222398A CN 104000777 B CN104000777 B CN 104000777B
Authority
CN
China
Prior art keywords
injection
add
water
levofloxacin
levofloxacin hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410222398.3A
Other languages
Chinese (zh)
Other versions
CN104000777A (en
Inventor
苏日佳
罗灼辉
孔祥生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Livzon Group Livzon Pharmaceutical Factory
Original Assignee
Livzon Pharmaceutical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Livzon Pharmaceutical Group Inc filed Critical Livzon Pharmaceutical Group Inc
Priority to CN201410222398.3A priority Critical patent/CN104000777B/en
Publication of CN104000777A publication Critical patent/CN104000777A/en
Application granted granted Critical
Publication of CN104000777B publication Critical patent/CN104000777B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of levofloxacin hydrochloride sodium chloride injection, it is characterised in that its prescription comprises: 20 parts of levofloxacin hydrochlorides; 0.1-0.2 part 2-amino-3-tolyl acid 10-15 part citric acid; 10-15 part Glacial acetic acid; Sodium hydroxide and water for injection.

Description

A kind of levofloxacin preparation
Technical field
The present invention relates to the injection field of chemicals, it is specifically related to levofloxacin preparation technique field.
Background technology
Levofloxacin (LevofloxacinHydrochloride) is the left-handed optical activity L-type isomer of Ofloxacine USP 23, and its anti-microbial activity is about 2 times of Ofloxacine USP 23, has has a broad antifungal spectrum, a feature that anti-microbial effect is strong. To most of enterobacteriaceae lactobacteriaceae, as the gram-negative bacterias such as escherichia coli, Klebsiella, Serratia, proteus, Shigella, Salmonella, citrobacter, acinetobacter and Pseudomonas aeruginosa, hemophilus influenzae, gonococcus have stronger anti-microbial activity. The gram positive organisms such as part methicillin-sensitivity staphylococcus, streptococcus pneumoniae, micrococcus scarlatinae, Hemolytic streptococcus and legionella, mycoplasma, chlamydozoan also there are is good anti-microbial effect, but the effect of anerobe and faecalis is poor.
Traditional method preparing levofloxacin hydrochloride sodium chloride injection, due to the defect in technique, after such as usually all raw material weighing is good during its preparation injection, add in the lump in charging tank, stirring and dissolving, due to different supplementary material different solubilities, the composition that solubleness is not good cannot dissolve completely, cause active constituent content not enough, affect the validity of product, in addition, the using method of Medicinal Charcoal routine directly joins in liquid, due to its light weight, easily assemble and float on liquid surface, disperse uneven, have impact on its adsorption effect, and, it easily disperses, deal with improperly and can pollute clean area and air conditioning and cleaning system, in conventional technique, also may there is the selection of pH scope or regulate improper, filter abundant not, sterilization temperature and mode are improper etc., cause the levofloxacin hydrochloride sodium chloride injection color adopting traditional method to prepare dark, clarity is poor, particulate is many, less stable, thus cause Clinical practice effect & Safety not good. not easily preserve, and result of use is not good, cause result for the treatment of not good.
Summary of the invention
The present invention proposes the preparation method of a kind of levofloxacin hydrochloride sodium chloride injection, solves in prior art the problems such as levofloxacin hydrochloride sodium chloride injection color is dark, clarity is poor, particulate is many, less stable, Clinical practice effect & Safety are not good.
The technical scheme of the present invention is prescription:
Further, prescription is preferably:
On the other hand, the technical scheme of the present invention is prepared by following preparation method:
(1) take 2-amino-3-tolyl acid, Glacial acetic acid, citric acid by recipe quantity, and add 25-45 DEG C of water for injection stirring and dissolving, inject water to the 20% of preparation cumulative volume;
(2) join after taking levofloxacin hydrochloride predissolve by recipe quantity in solution prepared by (1) step, and inject water to the 50% of preparation cumulative volume, stirring and dissolving, obtain just mixed liquid;
(3) add in solution sodium hydroxide then adjust ph to 6.5-7.0; Add injection water to full amount;
(4) 0.22 ��m of filtering with microporous membrane, are filled in the infusion bottle of sterilizing in advance by filtrate;
(5) 121 DEG C of hot steam sterilizers 20-30 minute;
(6) filtrate carries out assay, pH value and visible foreign matters inspection;
(7) carry out plug filling, upper after passed examination, roll lid, sterilizing, lamp inspection, packaging.
Compared with prior art, the Gatifloxacin and sodium chloride injection that the present invention relates to and its preparation method have following advantage and marked improvement:
(1) the injection stability prepared is higher, safe and reliable. Citric Acid is joined in levofloxacin injection liquid by the present invention, surprisingly finding through accelerated test, no longer there is precipitate in injection liquid, achieves unexpected effect, it is relevant that this may be easier to complexation of metal ions with citric acid, improves the security of medication well.
(2) preparation technology of injection liquid of the present invention is simple, is applicable to big production requirement.
Specific embodiment
Embodiment 1:
(1) prescription:
(2) preparation technology: take 2-amino-3-tolyl acid, Glacial acetic acid, citric acid by recipe quantity, and add 35 DEG C of water for injection stirring and dissolving, injects water to the 20% of preparation cumulative volume; Join after taking levofloxacin hydrochloride predissolve by recipe quantity in solution prepared by (1) step, and inject water to the 50% of preparation cumulative volume, stirring and dissolving, obtain just mixed liquid; Add in solution sodium hydroxide then adjust ph to 6.5-7.0; Add injection water to full amount; 0.22 ��m of filtering with microporous membrane, is filled in the infusion bottle of sterilizing in advance by filtrate; 121 DEG C of hot steam sterilizers 20-30 minute; Filtrate carries out assay, pH value and visible foreign matters inspection; Carry out plug filling, upper after passed examination, roll lid, sterilizing, lamp inspection, packaging.
Embodiment 2:
(1) prescription:
(2) preparation technology: take 2-amino-3-tolyl acid, Glacial acetic acid, citric acid by recipe quantity, and add 35 DEG C of water for injection stirring and dissolving, injects water to the 20% of preparation cumulative volume; Join after taking levofloxacin hydrochloride predissolve by recipe quantity in solution prepared by (1) step, and inject water to the 50% of preparation cumulative volume, stirring and dissolving, obtain just mixed liquid; Add in solution sodium hydroxide then adjust ph to 6.5-7.0; Add injection water to full amount; 0.22 ��m of filtering with microporous membrane, is filled in the infusion bottle of sterilizing in advance by filtrate; 121 DEG C of hot steam sterilizers 20-30 minute; Filtrate carries out assay, pH value and visible foreign matters inspection; Carry out plug filling, upper after passed examination, roll lid, sterilizing, lamp inspection, packaging.
Embodiment 3: the visible foreign matters of levofloxacin hydrochloride injection liquid and assay
In order to verify the stability of levofloxacin hydrochloride injection liquid prepared by the present invention, the injection liquid that specification sheets embodiment 1 of the present invention prepared, contrast A (injection liquid that CN101693008 embodiment 1 prepares), contrast B (injection liquid that CN103479522 specific embodiment prepares) three carry out the comparison of visible foreign matters inspection, assay. Experimentation result is as follows:
1. visible foreign matters inspection. Extract each embodiment sample, under being placed in 40 DEG C of environment, carry out accelerating to investigate. The results are shown in Table 1.
2. assay. Chromatographic column Shim-packGLC-ODS post (4.6mm �� 150mm, 5 ��m); Moving phase 0.02mol/L potassium dihydrogen phosphate (is adjusted to pH4.0 with phosphoric acid)-acetonitrile (85:15, containing 2mmol/L Tetrabutylammonium bromide); Flow velocity 1.0ml/min; Determined wavelength 292nm; Sample size 20 �� l; Post temperature is room temperature. The results are shown in Table 2.
Embodiment sample visible foreign matters measurement result before and after table 1 accelerated test
Embodiment samples contg measurement result before and after table 2 accelerated test
Sample source 0 day result 40 DEG C are accelerated 15 days results 40 DEG C are accelerated 180 days results
Embodiment 1 99.9% 99.9% 99.9%
Contrast A 99.9% 99.5% 94.0%
Contrast B 99.9% 98.2% 91.5%
From the experimental result of table 1, table 2 it will be seen that embodiment of the present invention sample is through accelerating to investigate, have no visible foreign matters, optimal stability.

Claims (3)

1. a levofloxacin hydrochloride sodium chloride injection, is characterised in that its prescription is:
2. injection liquid according to claim 1, is characterised in that its prescription is:
3. prepare a method for levofloxacin hydrochloride injection liquid, comprise the following steps:
(1) take the 2-amino-3-tolyl acid of 0.1-0.2g, the Glacial acetic acid of 10-15ml, the citric acid of 10-15ml, and add 25-45 DEG C of water for injection stirring and dissolving, inject water to 200ml;
(2) join after taking the levofloxacin hydrochloride predissolve of 20g in solution prepared by (1) step, and inject water to 500ml, stirring and dissolving, obtain just mixed liquid;
(3) add in solution sodium hydroxide then adjust ph to 6.5-7.0; Add injection water to 1000ml;
(4) 0.22 ��m of filtering with microporous membrane, are filled in the infusion bottle of sterilizing in advance by filtrate;
(5) 121 DEG C of hot steam sterilizers 20-30 minute;
(6) filtrate carries out assay, pH value and visible foreign matters inspection;
(7) carry out plug filling, upper after passed examination, roll lid, sterilizing, lamp inspection, packaging.
CN201410222398.3A 2014-05-21 2014-05-21 A kind of levofloxacin preparation Active CN104000777B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410222398.3A CN104000777B (en) 2014-05-21 2014-05-21 A kind of levofloxacin preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410222398.3A CN104000777B (en) 2014-05-21 2014-05-21 A kind of levofloxacin preparation

Publications (2)

Publication Number Publication Date
CN104000777A CN104000777A (en) 2014-08-27
CN104000777B true CN104000777B (en) 2016-06-01

Family

ID=51361873

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410222398.3A Active CN104000777B (en) 2014-05-21 2014-05-21 A kind of levofloxacin preparation

Country Status (1)

Country Link
CN (1) CN104000777B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110755374A (en) * 2019-11-22 2020-02-07 南京知和医药科技有限公司 Levofloxacin injection and preparation process thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1312366A1 (en) * 2000-08-08 2003-05-21 Wakamoto Pharmaceutical Co., Ltd. Aqueous pharmaceutical compositions
CN101693008A (en) * 2009-10-16 2010-04-14 蚌埠丰原涂山制药有限公司 Ofloxacin injection and preparation process thereof
CN102000083A (en) * 2010-11-30 2011-04-06 天津市汉康医药生物技术有限公司 Levofloxacin hydrochloride medicinal composition for injection and preparation method thereof
CN103479522A (en) * 2013-09-25 2014-01-01 海南华拓天涯制药有限公司 Method for preparing levofloxacin hydrochloride sodium chloride injection

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1312366A1 (en) * 2000-08-08 2003-05-21 Wakamoto Pharmaceutical Co., Ltd. Aqueous pharmaceutical compositions
CN101693008A (en) * 2009-10-16 2010-04-14 蚌埠丰原涂山制药有限公司 Ofloxacin injection and preparation process thereof
CN102000083A (en) * 2010-11-30 2011-04-06 天津市汉康医药生物技术有限公司 Levofloxacin hydrochloride medicinal composition for injection and preparation method thereof
CN103479522A (en) * 2013-09-25 2014-01-01 海南华拓天涯制药有限公司 Method for preparing levofloxacin hydrochloride sodium chloride injection

Also Published As

Publication number Publication date
CN104000777A (en) 2014-08-27

Similar Documents

Publication Publication Date Title
CN103989630B (en) Moxifloxacin hydrochloride injection and preparation method thereof
CN102512380A (en) Freeze-dried powder injection with omeprazole sodium as active component and preparation method thereof
CN103479522B (en) A kind of preparation method of levofloxacin hydrochloride and sodium chloride injection
CN104000777B (en) A kind of levofloxacin preparation
CN105640876B (en) A kind of preparation process of moxifloxacin hydrochloride injection
CN102836123A (en) Injection containing levetiracetam active ingredient and technology for preparing injection
CN103948632A (en) Medical application of toad-feeding maggot antibacterial peptide
CN103315951B (en) Low-molecular-weight heparin calcium injection
CN102908312B (en) Liquid combination for resisting hepatitis B viruses
CN101993503A (en) Method for preparing powdered sodium hyaluronate
CN103239394A (en) Small-volume moxifloxacin hydrochloride injection and preparation method thereof
CN108685846B (en) Levofloxacin hydrochloride injection and preparation method thereof
CN111870578A (en) Mequindox injection and preparation method thereof
CN101199514A (en) Ketoralac ammonia butanetriol injection and preparing method thereof
CN103919779B (en) A kind of pharmaceutical composition containing Moxifloxacin
CN102311358A (en) Calcium disodium edetate sterile raw material medicine and production process thereof
CN102871973A (en) Omeprazole sodium freeze-drying preparation and preparation method thereof
CN102584862A (en) Biapenem crystalline compound and composition powder-needle thereof
CN106420599A (en) Preparation method of citric acid caffeine injection
CN104288099A (en) Ibuprofen injection
CN103432086A (en) Pemetrexed disodium freeze-dried powder injection for injection and preparation method thereof
CN108836945A (en) A kind of preparation method of Potassium DehydroandrograpolidSuccinate Succinate for Injection freeze drying powder injection
CN104224707A (en) Granisetron hydrochloride glucose injection and preparation method thereof
CN105232478B (en) Amino acid injection-800 freeze-dried powder and preparation method thereof
CN103980327A (en) Preparation method of highly pure mycose used for medicinal injections

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
DD01 Delivery of document by public notice

Addressee: Kuang Lijuan

Document name: Notification of Passing Examination on Formalities

C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20190812

Address after: 519090 No. 38 Pioneer North Road, Jinwan District, Zhuhai City, Guangdong Province

Patentee after: Livzon Group Livzon Pharmaceutical Factory

Address before: 510000 Administrative R&D Building, No. 38 Pioneering North Road, Shuanglin District, Lianggang Industrial Zone, Hongqi Town, Jinwan District, Zhuhai City, Guangdong Province

Patentee before: Lizhu Medicine Group Co., Ltd.

TR01 Transfer of patent right